A critical advance in cancer study is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in various kinds of tumors, causing https://tinybookmarks.com/story21908344/vhh-fragments-reactivate-tumor-suppressor-p53-a-promising-hope-for-tumor-therapy